Claudio Pirozzi Selected Research

Claudio Pirozzi Research Topics

Disease

15	Inflammation (Inflammations) 01/2023 - 06/2015
8	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 01/2017
6	Insulin Resistance 05/2022 - 04/2016
4	Neuroinflammatory Diseases 06/2022 - 01/2019
4	Obesity 01/2022 - 07/2016
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2020 - 06/2015
2	Dysbiosis 06/2023 - 06/2022
2	Fibrosis (Cirrhosis) 11/2020 - 01/2020
2	Colitis 01/2017 - 06/2015
2	Hypertension (High Blood Pressure) 01/2015 - 10/2013
1	Albuminuria 01/2024
1	Overnutrition 01/2023
1	Parkinson Disease (Parkinson's Disease) 06/2022
1	Psychotic Disorders (Schizoaffective Disorder) 05/2022
1	Neuroblastoma 01/2022
1	Memory Disorders (Memory Loss) 01/2021
1	Mental Fatigue 01/2021
1	Ulcerative Colitis 09/2020
1	Pain (Aches) 09/2020
1	Immediate Hypersensitivity 10/2019
1	Atrophy 01/2018
1	Cholestasis 01/2018
1	Babesiosis (Piroplasmosis) 01/2018
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2018
1	Hyperglycemia 01/2017
1	Fatty Liver 01/2017
1	Shock 01/2017
1	Milk Hypersensitivity (Milk Allergy) 01/2017
1	Anaphylaxis (Anaphylactic Shock) 01/2017
1	Arthritis (Polyarthritis) 07/2016
1	Osteoarthritis 07/2016
1	Rheumatoid Arthritis 07/2016
1	Rheumatic Diseases (Rheumatism) 07/2016
1	Non-alcoholic Fatty Liver Disease 04/2016
1	Herpes Zoster 04/2016

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 05/2022 - 04/2016
6	CytokinesIBA 01/2022 - 01/2017
4	Butyrates (Butyrate)IBA 06/2022 - 01/2017
4	AntioxidantsIBA 05/2022 - 01/2019
4	palmidrolIBA 01/2022 - 01/2015
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 01/2015
3	LipidsIBA 01/2023 - 01/2020
3	Butyric Acid (Butanoic Acid)IBA 06/2022 - 01/2018
3	Fatty Acids (Saturated Fatty Acids)IBA 09/2020 - 01/2020
3	AdipokinesIBA 01/2018 - 07/2016
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 06/2023 - 06/2022
2	Oxidopamine (6 Hydroxydopamine)IBA 06/2023 - 06/2022
2	Hormones (Hormone)IBA 05/2022 - 05/2020
2	NF-kappa B (NF-kB)IBA 11/2020 - 09/2020
2	InflammasomesIBA 11/2020 - 01/2020
2	Endocrine DisruptorsIBA 11/2020 - 05/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 04/2016
2	LigandsIBA 01/2020 - 10/2013
2	Immunoglobulin E (IgE)IBA 10/2019 - 01/2017
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2019 - 11/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2016
2	Dextrans (Dextran)FDA Link 01/2017 - 06/2015
2	butyramideIBA 01/2017 - 01/2017
2	PolyphenolsIBA 01/2017 - 04/2016
2	Therapeutic UsesIBA 04/2016 - 06/2015
1	CreatinineIBA 01/2024
1	Oxidants (Oxidizing Agents)IBA 05/2022
1	Glucosamine (Dona)IBA 01/2022
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2022
1	Nonesterified Fatty Acids (NEFA)IBA 01/2022
1	Triglycerides (Triacylglycerol)IBA 11/2020
1	bisphenol AIBA 11/2020
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 09/2020
1	EnzymesIBA 05/2020
1	Interleukin-18 (Interleukin 18)IBA 01/2020
1	Conjugated Linoleic AcidsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Aquaporins (Water Channels)IBA 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	ProdrugsIBA 01/2018
1	Estrogens (Estrogen)FDA Link 01/2018
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2018
1	Olive OilIBA 01/2017
1	SodiumIBA 01/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	Interleukin-5 (Interleukin 5)IBA 01/2017
1	Caseins (Casein)FDA Link 01/2017
1	Interleukin-13IBA 01/2017
1	Raloxifene Hydrochloride (Evista)FDA Link 01/2017
1	Persistent Organic PollutantsIBA 07/2016
1	Environmental Pollutants (Pollutants, Environmental)IBA 07/2016
1	Polychlorinated Biphenyls (PCBs)IBA 07/2016
1	Messenger RNA (mRNA)IBA 04/2016
1	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 04/2016
1	fluorescein isothiocyanate dextranIBA 04/2016
1	oleuropeinIBA 04/2016
1	CholesterolIBA 04/2016
1	Drinking WaterIBA 06/2015
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 06/2015
1	Angiotensin IIIBA 10/2013
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 10/2013

Therapy/Procedure

2	Therapeutics 01/2021 - 06/2015